Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
Thomas Jefferson University
Thomas Jefferson University
Klus Pharma Inc.
Quadriga Biosciences, Inc.
Stanford University
Alliance for Clinical Trials in Oncology
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)